14158 Results (Page 94 of 567)
All Market Research Reports
Brazil Pain Management Devices Market Analysis
This report presents a strategic analysis of the Brazil Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
Turkey Dermatological Therapeutics Market Analysis
This report presents a strategic analysis of the Turkey Dermatological Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey Dermatological Therapeutics Market, offering unmatched value, accuracy and expert insights.
Brazil Mucopolysaccharidosis I (MPS-I) Drugs Market Analysis
Brazil Mucopolysaccharidosis I (MPS-I) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Rising consumer awareness, new drug approvals, enticing reimbursement plans, an established healthcare system, and the presence of sizable market competitors all drive the market for treating Mucopolysaccharidosis I. Major global players in Mucopolysaccharidosis I (MPS-I) Drugs Market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Sarepta Drugs, Abeona Drugs, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Drugs, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd.
Brazil Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
Brazil's Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is expected to grow from $93 Mn in 2022 to $216 Mn in 2030 with a CAGR of 11.20% for the year 2022-30. The expansion of the PNH therapeutics market in Brazil is anticipated to be fueled by the creation of new technologies and treatment options for PNH. For instance, the recent approval of eculizumab (a monoclonal antibody that targets the complement system for the treatment of PNH) has dramatically improved patient outcomes and is probably going to lead to a rise in the demand for PNH medicines in Brazil. The market is segmented by therapy, diagnostic test, and distribution channel. Some key players in this market include Aché Laboratórios, Eurofarma, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring, and Bioverativ.
Brazil Oculopharyngeal Muscular Dystrophy (OPMD) Market Analysis
Brazil Oculopharyngeal Muscular Dystrophy (OPMD) market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Oculopharyngeal Muscular Dystrophy (OPMD)is growing due to increase spending in research and development activities by pharmaceutical companies, incentives provided by regulatory authorities like orphan drug designations and accelerated approval pathways, patient support and advocacy programmes which help to increase awareness about disease and provide support to patients. Bristol-Myers Squibb, BioMarin, Sarepta Therapeutics, Benitec Biopharma Inc., Bioblast Pharma, PTC Therapeutics, NS Pharma, Nobelpharma Co., Ltd ,Santhera Pharmaceuticals, Pfizer Inc. ,Marathon Pharmaceuticals, Fibrogen, GSK are the key global market players.
Argentina Depression Therapeutics Market Analysis
This report presents a strategic analysis of the Argentina Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Depression Therapeutics Market, offering unmatched value, accuracy and expert insights.
Brazil Mucopolysaccharidosis I (MPS-I) Therapeutics Market Analysis
Brazil Mucopolysaccharidosis I (MPS-I) therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Rising consumer awareness, new drug approvals, enticing reimbursement plans, an established healthcare system, and the presence of sizable market competitors all drive the market for treating Mucopolysaccharidosis I. Major global players in this market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Sarepta Therapeutics, Abeona Therapeutics, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Therapeutics, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd.
Europe Dental Care Market Analysis
Europe's dental care market size is at around $6.81 Bn in 2022 and is projected to reach $10.18 Bn in 2030, exhibiting a CAGR of 5.14% during the forecast period. Post Brexit, the UK essentially relies on NHS for dental care services and other European Union states have a mixture of public and private healthcare providers to contribute to this endeavour. Driven by the needs of the aging population in Europe and the increased rate of migration from the Middle East due to the acceptance of refugees, dental care needs are reported to shift drastically over the next years. Major players include – Smysecret, Tandartspraktijk Praktijk Noord, Dental Clinic Denmark, Irish Dental Care, and Dentales. This report is segmented by treatment type, age group, clinical setup, and by demography and provides in-depth insights into opportunities for strategic placement of ventures in the region of Europe.
Saudi Arabia Dental Care Market Analysis
Saudi Arabia's dental care market size is at around $287.04 Mn in 2022 and is projected to reach $489.51 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. Saudi Arabia is a pilgrim tourism destination due to Hajj and Umrah (6.5 Mn visitors in 2021) and a growing expat population due to “Vision 2030” to enhance its oil-based economy. This market is captured by dental care clinics like AlMouwasat Medical Services, Alhokair Dental Center, and Alhada Dental Center. This report is segmented by treatment type, age group, clinical setup, and demography (including migrating population) and provides rich insights for dental corporations to identify and target their potential market.
Egypt Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Egypt Nutrition and Supplements market will reach a value of $2.29 Bn from $1.07 Bn in 2022, growing at a CAGR of 10% during 2022-2030. The nutritional supplements market in Egypt is primarily dominated by local players such as Amoun Pharmaceutical, Pharmed Healthcare, and EVA Pharma. The market for nutrition and supplements in the Egypt is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Egypt nutrition and supplements market in Egypt is segmented by Type, Product, application, and Distribution Channel.
Canada Telemedicine Market Analysis
The Canada Telemedicine market was valued at $4.864 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 18.2% from 2022 to 2030 and will reach $18.532 Bn in 2030. One of the main reasons propelling the growth of this market is the advent of advanced technologies, rising cases of chronic and lifestyle related disease. The market is segmented by end user, product type and Delivery mode. Some key players in this market are Cerner Corporation, GE Healthcare, Physiotherapy Ltd etc.
India Digital Health Market Analysis
India's digital health market is projected to grow from $3.83 Bn in 2022 to $18.34 Bn by 2030, registering a CAGR of 21.6% during the forecast period of 2022-30. A combination of a large potential market and supportive government policies is expected to drive strong growth in the India digital health market in the coming years. The market is segmented by solution, by deployment, by end-use. Some of the major players include Practo Technologies Pvt. Ltd, Philips Healthcare & Siemens Healthcare Pvt.
India Oncology Drugs Market Analysis
By 2030, it is anticipated that the India oncology drugs market will reach a value of $10.6 Bn from $3.6 Bn in 2022 and is expected to grow at a CAGR of 14.6% during 2022-30. The companies operating in the oncology drug in India market are Roche Diagnostics, Novartis Oncology and Celgene Corporation. This market is segmented on the basis of therapy modality and types of cancer. Factors such as increased awareness about cancer and its treatments, rising disposable incomes, and improved access to healthcare are some of the major drivers of growth in the Indian oncology drug market.
US Pharmaceutical Market Analysis
The US Pharmaceutical Market is projected to grow from $567 Bn in 2022 to $903 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The US pharmaceutical market is characterized by a high degree of competition and consolidation, with a few large companies dominating the industry. Some of the top pharmaceutical companies in the US include Pfizer, Johnson & Johnson, Merck & Co., and AbbVie.
Vietnam Dental Care Market Analysis
Vietnam's dental care market was valued at $6.595 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.93% from 2022 to 2030 and will reach $15.122 Bn in 2030. One of the main reasons propelling the growth of this market demand for primary and postoperative care of higher quality is technological advancement. The market is segmented by services, dental clinics, and revenue. Some key players in this market are Nha Khoa Kim, Nha Khoa Paris Dental Group, Nha Khoa Dang Luu, Anna Dental Care, etc.
India Clinical Diagnostics Market Analysis
India's clinical diagnostic market was valued at $1.25 Bn in 2022 and is estimated to expand at a CAGR of 9% from 2022-30 and will reach $2.5 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thyrocare, Suburban Diagnostics, Metropolis Healthcare, SRL Diagnostics, Dr. Lal PathLabs, and others.
Canada Pharmaceutical Market Analysis
Canada's pharmaceutical market size is about $83.08 Bn in 2022 and is expected to witness significant growth of about $141.69 Bn in 2030 with a CAGR of 6.9% as there are a large number of overseas pharmaceutical companies having a presence in Canada. The incidences of chronic diseases among the Canadian population and comorbidities associated with the diseases are likely to positively impact the growth of the pharmaceutical market over the forecast period. The market is segmented by formulation type, route of administration type and prescription type, etc. Some of the leading players in the market are Pfizer, Novartis AG, and Roche.
France Retail Pharmacy Market Analysis
France's Retail Pharmacy Market is projected to grow from $28.56 Bn in 2022 to $45.18 Bn by 2030, registering a CAGR of 5.9% during the forecast period of 2022-2030. The government plays a significant role in the market through its reimbursement policies and regulations, which can impact the profitability of pharmacies. The main player in the France retail pharmacy market is Groupe A.S.P, which is a retail pharmacy chain with more than 600 stores across the country.
Global Physiotherapy Market Analysis
The global physiotherapy market size was valued at $15.35 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 16.3% from 2022 to 2030 and will reach $51.37 Bn in 2030. The Global physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an ageing population. The market is segmented by Product Type Application Type and End User. The major players in the Global physiotherapy market are PhysioGlobal, BTL, EMS Physio Ltd., Dynatronics Corporation, RICHMAR, and others.
Canada Physiotherapy Market Analysis
Canada's physiotherapy market size was valued at $4.25 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.85% from 2022 to 2030 and will reach $6.70 Bn in 2030. The Canada physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The major players in the Canada physiotherapy market are BTL Industries, Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
Australia Diagnostic Imaging Services Market Analysis
Australia's Diagnostic Imaging Services market size was valued at $6.3 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $10.3 Bn in 2030. The market is segmented by product, application, and end user. The Australia Diagnostic Imaging Services market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited (AUS), I-MED Radiology Network (AUS), Capitol Health Limited (AUS), Integral Diagnostics Limited (AUS), and others.
Brazil Chronic Myelogenous Leukemia Therapeutics Market Analysis
Brazil Chronic Myelogenous Leukemia Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Chronic granulocytic leukemia, often known as chronic myelogenous leukemia (CML), is a slowly progressive blood and bone marrow condition that most frequently affects adults in or after middle age and very infrequently affects children. Because of the rising incidence of the condition, the introduction of novel medications, and the expanding use of personalized medicine, the market for CML treatments is anticipated to expand gradually in the years to come. Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, and Sanofi are a few of the businesses that are now dominating the industry.
Brazil Artificial Intelligence (AI) in Diagnostics Market Analysis
Brazil's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.03 Bn in 2022 to $0.29 Bn by 2030, registering a CAGR of 36% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of chronic illnesses and the growing requirement for more accurate and efficient diagnostic instruments. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & HiLab.
Brazil Autoimmune Hemolytic Anemia Drugs Market Analysis
Brazil Autoimmune Hemolytic Anemia Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. A rise in the prevalence of certain autoimmune illnesses and malignancies, as well as increased funding for research into innovative interventions and growing demand for novel therapies, are all contributing to an increase in the market for medications to treat autoimmune hemolytic anaemia. Major global players in Autoimmune Hemolytic Anemia Drugs Market are F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Vertice Pharma, Concord Biotech, Alkem Labs, Dr. Reddy's Laboratories Ltd, Jubilant Life Sciences Ltd, Strides Pharma Science Limited, Mylan N.V., Novartis AG, Sanofi, Rigel Pharmaceuticals Inc, Incyte Corporation, Alexion Pharmaceuticals, Apellis Pharmaceuticals.
South Korea Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the South Korean infectious disease therapeutics market will reach a value of $2.66 Bn from $1.75 Bn in 2022, growing at a CAGR of 5.4% during 2022-2030. Infectious Disease Therapeutics in South Korea is dominated by a few domestic pharmaceutical companies such as Green Cross Corporation, SK Bioscience and GC Pharma. The Infectious Disease Therapeutics market in South Korea is segmented into different therapeutic areas and different diseases type. The major factors affecting the South Korean infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of South Korea.
